VG

Vaibhav Gupta

Active Director Director DIN 08082671
DIN 08082671 First appointment Mar 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Vaibhav Gupta

Data last updated:

Vaibhav Gupta is a Director at Aspiris Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Aspiris Pharmaceuticals Private Limited reported revenue of ₹14.4 Lakh (FY 2024).

DIN 08082671
Primary Designation Director
Industry Chemicals
First Appointment 10 Mar 2018
Oldest Company Age 13 yrs
Largest company Aspiris Pharmaceuticals Private Limited · ₹14.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Mar 20182012₹14.4 Lakh (FY 2024)Active

Board colleagues of Vaibhav Gupta

Directorship timeline

Open interactive timeline →
Aspiris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vaibhav Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaibhav Gupta

Vaibhav Gupta currently holds 1 directorship: Aspiris Pharmaceuticals Private Limited (Director, since 10 Mar 2018, revenue ₹14.4 Lakh (FY 2024)).

Vaibhav Gupta was first appointed on 10 Mar 2018 as Director at Aspiris Pharmaceuticals Private Limited.

The current boards of Vaibhav Gupta's companies include Gagan Deep Jha (Aspiris Pharmaceuticals Private Limited), Monika Gupta (Aspiris Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available